Clene (NASDAQ: CLNN) reported its Q3 2024 financial results and provided updates on its CNM-Au8 programs. Key operational highlights included a recent FDA meeting to discuss the potential for ...
The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...
Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback